Merck Challenges U.S. Government’s New Powers to Negotiate Drug Prices

This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com.

https://www.wsj.com/articles/merck-challenges-u-s-governments-new-powers-to-negotiate-drug-prices-127d4b0c Drugmaker’s lawsuit says Medicare’s drug-price negotiation program violates the company’s constitutional rights

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Cancer vaccines poised to unlock 'new treatment paradigm' with Merck/Moderna dataAdding an experimental mRNA-based vaccine from Moderna Inc and Merck & Co reduced the risk that the most deadly skin cancer would spread by 65% over treatment with an immunotherapy alone in a midstage trial, the companies reported on Monday.
Source: Reuters - 🏆 2. / 97 Read more »

Cancer vaccines poised to unlock 'new treatment paradigm' with Merck/Moderna dataAn experimental mRNA-based vaccine from Moderna and Merck reduced the risk that the most deadly skin cancer would spread, by 65%, compared to immunotherapy treatment alone, the companies reported on Monday.
Source: KSLcom - 🏆 549. / 51 Read more »